MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Visual hallucinations in Parkinson´s disease and amyloid burden: 18F-Flutemetamol PET-MRI study

    B. Fernández-Rodríguez, C. Gasca-Salas, R. Rodríguez-Rojas, P. Guida, D. Mata-Marín, I. Obeso-Martín, L. Vela, M. Garcerant-Tafur, L. García-Cañamaque, JA. Obeso (Móstoles, Spain)

    Objective: To compare amyloid distribution in patients with Parkinson´s disease (PD) with visual hallucinations (VH-p) and without (VH-n). Background: In patients with PD the prevalence…
  • 2019 International Congress

    Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson’s Disease

    E. Fiorenzato, A. Antonini, V. Camparini, L. Weis, C. Semenza, R. Biundo (Venice, Italy)

    Objective: This study investigated neuropsychological tests most sensitive in differentiating progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple system atrophy (MSA), and in…
  • 2019 International Congress

    The Promise of Automation: Development and preliminary testing of a language-based machine learning algorithm in PD

    B. Fujii, R. Richter, A. Roberts (Evanston, IL, USA)

    Objective: The proposed work seeks to expand current machine learning algorithms in PD using both motor and language features to discriminate affected speakers from healthy…
  • 2019 International Congress

    Severe hypomimia in drug naïve Parkinson´s disease patients may predict mild cognitive impairment

    C. Gasca-Salas, L. Vela, J. Obeso (Alcorcón, Spain)

    Objective: We aimed to analyze if hypomimia was associated with mild cognitive impairment in Parkinson´s disease  (PD-MCI) and if it predicted cognitive decline. Background: Hypomimia…
  • 2019 International Congress

    Procedural Memory Changes of Parkinson’s Disease Patients Post Participation in Boxing

    A. Ghaffar, R. Gallagher, C. Mcleod, A. Leder (Old Westbury, NY, USA)

    Objective: Can participation in a Rock Study Boxing program improve procedural memory in people with Parkinson’s disease (PD)? Background: Procedural memory is important for daily…
  • 2019 International Congress

    Verbal Disfluencies in Parkinson´s Disease Spoken Discourse as a Function of Syntax Complexity

    S. Gutierrez, K. Aveni, A. Torani, A. Roberts (Evanston, IL, USA)

    Objective: To evaluate the effects of syntax complexity on the frequency of verbal disfluencies in individuals with PD and healthy controls (HC) during spontaneous speaking…
  • 2019 International Congress

    Comparing motor and neuropathological features of Parkinson’s disease dementia and dementia with Lewy bodies

    D. Hansen, T. Lashley, J. Holton, T. Warner (London, United Kingdom)

    Objective: To compare motor and neuropathological features of Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) and to determine clinical and neuropathological differences…
  • 2019 International Congress

    Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD

    S. Holden, L. Medina, A. Simpson, B. Kluger (Aurora, CO, USA)

    Objective: Evaluate concordance between self-reported and performance-based measures of cognitive functional abilities in PD by cognitive class. Background: PD-specific cognitive functional questionnaires, the Penn Daily…
  • 2019 International Congress

    Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways

    JJ. Hu, T. Wang (Wuhan, China)

    Objective: To investigate the role and mechanism of C3a receptor in okadaic acid(OA) induced SH-SY5Y cells tau hyperphosphorylation model Background: Neurofibrillary tangles aggregated from hyperphosphorylated…
  • 2019 International Congress

    Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease

    H. Jeong, H. Kang (Changwon, Republic of Korea)

    Objective: Investigate the relationship between global and specific cognitive functions and PIGD symptoms in Parkinson’s disease Background: It is well known that cognition and motor…
  • « Previous Page
  • 1
  • …
  • 1140
  • 1141
  • 1142
  • 1143
  • 1144
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley